TABLE 2.
Neurochemical and hormonal regulation of ejaculation.
| Neurotransmitter/hormone | Effect |
|---|---|
| Dopamine | Stimulates ejaculation through D2-like receptors (D2, D3, and D4 receptors, mainly D3) |
| Serotonin | Inhibits ejaculation in the brain and stimulates it in the spine through the receptors 5HT, with 1A, 1B, and 2C |
| Nitric oxide | Inhibits ejaculation through reduction of seminal vesicle contraction and seminal emission |
| Oxytocin | Synthesized in the supraoptic and PVN of the hypothalamus and released from the posterior pituitary gland |
| Augments powerful epididymal contractions and sperm motility | |
| Acts in the CNS to stimulate ejaculation | |
| Prolactin | Secreted from the pituitary gland |
| Hyperprolactinemia has a marked inhibitory effect on male sexual desire, through inhibition of GnRH (therefore T production) and dopamine production | |
| Thyroid hormones | Hypothyroidism and hyperthyroidism are associated with delayed and premature ejaculation, respectively |
| Glucocorticoids | Cortisol levels are elevated after ejaculation in animal studies |
| No change in cortisol levels in humans | |
| Replacement of cortisol in Addison disease improves sexual function including orgasm | |
| Estrogens | Regulates the emission phase of ejaculation through the regulation of epididymal contractility, luminal fluid reabsorption, and sperm concentration |
| Androgens | Low levels are associated with delayed ejaculation, whereas high levels are associated with premature ejaculation |
| Facilitates the control of the ejaculatory reflex through its androgen receptors in the MPOA and other areas in the CNS | |
| Pelvic floor muscles involved in ejaculation are androgen dependent |
Note: CNS = central nervous system; MPOA = medial preoptic area; PVN = paraventricular nucleus.